{
    "id": "362305bc-03d1-9d6c-e063-6294a90ac959",
    "indications": {
        "text": "topical corticosteroids indicated relief inflammatory pruritic manifestations corticosteroid-responsive dermatoses .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "apply affected area thin film follows : triamcinolone acetonide cream usp , 0.025 % two four times daily ; triamcinolone acetonide cream usp , 0.1 % 0.5 % two three times daily depending severity condition . occlusive dressings may used management psoriasis recalcitrant conditions . infection develops , occlusive dressings discontinued appropriate antimicrobial therapy instituted .",
        "doid_entities": [
            {
                "text": "psoriasis (DOID:8893)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8893"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "triamcinolone acetonide cream usp , 0.025 % triamcinolone acetonide cream usp , 0.1 % 15 gram tubes ndc 0168-0003-15 15 gram tubes ndc 0168-0004-15 80 gram tubes ndc 0168-0003-80 80 gram tubes ndc 0168-0004-80 1 lb jars ndc 0168-0004-16 triamcinolone acetonide cream usp , 0.5 % 15 gram tubes ndc 0168-0002-15. store controlled room temperature 15\u00b0-30\u00b0c ( 59\u00b0-86\u00b0f ) . avoid excessive heat . protect freezing . fougera pharmaceuticals inc. e. fougera & co. division fougera pharmaceuticals inc. melville new york 11747 i20215g/if20215g r09/11 # 227 46165001a r06/15 # 65",
    "adverseReactions": "topical corticosteroids contraindicated patients history hypersensitivity components preparation .",
    "ingredients": [
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL PALMITATE",
            "code": "8CRQ2TH63M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_84262"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "LACTIC ACID, UNSPECIFIED FORM",
            "code": "33X04XA5AT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "TRIAMCINOLONE ACETONIDE",
            "code": "F446C597KA",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_71418"
        }
    ],
    "organization": "REMEDYREPACK INC.",
    "name": "triamcinolone acetonide",
    "effectiveTime": "20250527",
    "indications_original": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications_original": "Apply to the affected area as a thin film as follows: Triamcinolone Acetonide Cream USP, 0.025% two to four times daily; Triamcinolone Acetonide Cream USP, 0.1% and 0.5% two or three times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions_original": "Triamcinolone Acetonide Cream USP, 0.025%\n                           \n                           \n                              Triamcinolone Acetonide Cream USP, 0.1%\n                           \n                        \n                        \n                           \n                              15 gram tubes\u00a0\u00a0\u00a0NDC 0168-0003-15\n                           \n                           \n                              15 gram tubes\u00a0\u00a0\u00a0NDC 0168-0004-15\n                           \n                        \n                        \n                           \n                              80 gram tubes\u00a0\u00a0\u00a0NDC 0168-0003-80\n                           \n                           \n                              80 gram tubes\u00a0\u00a0\u00a0NDC 0168-0004-80\n                           \n                        \n                        \n                           \n                              \u00a0\n                           \n                           \n                              1 Lb jars\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NDC 0168-0004-16\n                           \n                        \n                        \n                           \n                              Triamcinolone Acetonide Cream USP, 0.5%\n                           \n                           \n                              \u00a0\n                           \n                        \n                        \n                           \n                              15 gram tubes\u00a0\u00a0 NDC 0168-0002-15.\n                           \n                           \n                              \u00a0\n                           \n                        \n                     \n                  \n                  Store at controlled room temperature 15\u00b0-30\u00b0C (59\u00b0-86\u00b0F).\n                  Avoid excessive heat. Protect from freezing.\n                  \n                     Fougera\n                     PHARMACEUTICALS INC.\n      \n\n \n                  E. FOUGERA & CO.\n       \n \n  A division of Fougera Pharmaceuticals Inc.\n       \n \n  Melville New York 11747\n      \n\n \n                  I20215G/IF20215G\n       \n \n  R09/11\n       \n \n  #227\n      \n\n \n                  46165001A\n                  R06/15\n                  #65",
    "adverseReactions_original": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.",
    "drug": [
        {
            "name": "triamcinolone acetonide",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_71418"
        }
    ]
}